Published in Am J Pathol on July 01, 2000
Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction. Nat Biotechnol (2013) 2.11
Decreased thickness and integrity of the macular elastic layer of Bruch's membrane correspond to the distribution of lesions associated with age-related macular degeneration. Am J Pathol (2005) 1.92
Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp Eye Res (2005) 1.84
Animal models of choroidal and retinal neovascularization. Prog Retin Eye Res (2010) 1.79
Recent perspectives in ocular drug delivery. Pharm Res (2008) 1.72
Role of growth factors and the wound healing response in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2003) 1.64
Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium. Am J Pathol (2001) 1.53
Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA). Br J Ophthalmol (2014) 1.41
VEGF regulates local inhibitory complement proteins in the eye and kidney. J Clin Invest (2016) 1.39
Animal models of age related macular degeneration. Mol Aspects Med (2012) 1.39
Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A. J Clin Invest (2006) 1.36
Spare the rod and spoil the eye. Br J Ophthalmol (2005) 1.28
[Intravitreal bevacizumab for neovascular age-related macular degeneration]. Ophthalmologe (2006) 1.20
Identification of Chlamydia pneumoniae within human choroidal neovascular membranes secondary to age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2005) 1.20
Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications. Mediators Inflamm (2010) 1.11
A subretinal matrigel rat choroidal neovascularization (CNV) model and inhibition of CNV and associated inflammation and fibrosis by VEGF trap. Invest Ophthalmol Vis Sci (2010) 1.06
Regulated secretion of complement factor H by RPE and its role in RPE migration. Graefes Arch Clin Exp Ophthalmol (2009) 1.05
Effects of bevacizumab on retinal function in isolated vertebrate retina. Br J Ophthalmol (2006) 1.02
Alterations of retinal pigment epithelium cause AMD-like retinopathy in senescence-accelerated OXYS rats. Aging (Albany NY) (2011) 1.01
Progressive dysfunction of the retinal pigment epithelium and retina due to increased VEGF-A levels. FASEB J (2014) 0.98
Clinical and differential utility of VEGF inhibitors in wet age-related macular degeneration: focus on aflibercept. Clin Ophthalmol (2012) 0.97
Doxycycline-mediated inhibition of choroidal neovascularization. Invest Ophthalmol Vis Sci (2009) 0.95
Delivery of celecoxib for treating diseases of the eye: influence of pigment and diabetes. Expert Opin Drug Deliv (2010) 0.94
Therapeutic action of the mitochondria-targeted antioxidant SkQ1 on retinopathy in OXYS rats linked with improvement of VEGF and PEDF gene expression. PLoS One (2011) 0.94
An apolipoprotein E variant may protect against age-related macular degeneration through cytokine regulation. Environ Mol Mutagen (2006) 0.94
Ablation of 4E-BP1/2 prevents hyperglycemia-mediated induction of VEGF expression in the rodent retina and in Muller cells in culture. Diabetes (2010) 0.93
Topical antiangiogenic SRPK1 inhibitors reduce choroidal neovascularization in rodent models of exudative AMD. Invest Ophthalmol Vis Sci (2013) 0.92
Controversial view of a genetically altered mouse model of focal retinal degeneration. Bioengineered (2012) 0.92
The choroid as a sclera growth regulator. Exp Eye Res (2013) 0.92
Variants in the APOE gene are associated with improved outcome after anti-VEGF treatment for neovascular AMD. Invest Ophthalmol Vis Sci (2011) 0.90
Nanoceria inhibit expression of genes associated with inflammation and angiogenesis in the retina of Vldlr null mice. Exp Eye Res (2013) 0.89
Matrix metalloproteinases in human choroidal neovascular membranes excised following verteporfin photodynamic therapy. Br J Ophthalmol (2007) 0.89
Age-related macular degeneration and changes in the extracellular matrix. Med Sci Monit (2014) 0.88
PlGF gene knockdown in human retinal pigment epithelial cells. Graefes Arch Clin Exp Ophthalmol (2010) 0.88
Attenuation of choroidal neovascularization by β(2)-adrenoreceptor antagonism. JAMA Ophthalmol (2013) 0.87
Platelet-derived growth factor-DD targeting arrests pathological angiogenesis by modulating glycogen synthase kinase-3beta phosphorylation. J Biol Chem (2010) 0.87
A reproducible and quantifiable model of choroidal neovascularization induced by VEGF A165 after subretinal adenoviral gene transfer in the rabbit. Mol Vis (2008) 0.86
Pharmacokinetics of intravitreally injected bevacizumab in vitrectomized eyes. J Ocul Pharmacol Ther (2013) 0.86
Generation of transgenic mice with mild and severe retinal neovascularisation. Br J Ophthalmol (2005) 0.85
Rac1 activates HIF-1 in retinal pigment epithelium cells under hypoxia. Graefes Arch Clin Exp Ophthalmol (2009) 0.84
Glycoxidized particles mimic lipofuscin accumulation in aging eyes: a new age-related macular degeneration model in rabbits. Graefes Arch Clin Exp Ophthalmol (2007) 0.84
KRIT1 protein depletion modifies endothelial cell behavior via increased vascular endothelial growth factor (VEGF) signaling. J Biol Chem (2014) 0.84
Roles of NFκB-miR-29s-MMP-2 circuitry in experimental choroidal neovascularization. J Neuroinflammation (2014) 0.83
Aflibercept in wet age-related macular degeneration: a perspective review. Ther Adv Chronic Dis (2012) 0.83
FLT1 genetic variation predisposes to neovascular AMD in ethnically diverse populations and alters systemic FLT1 expression. Invest Ophthalmol Vis Sci (2014) 0.82
Ligand-functionalized nanoparticles target endothelial cells in retinal capillaries after systemic application. Proc Natl Acad Sci U S A (2013) 0.82
Effect of verteporfin photodynamic therapy on endostatin and angiogenesis in human choroidal neovascular membranes. Br J Ophthalmol (2006) 0.82
Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review. Drug Des Devel Ther (2016) 0.82
Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide. Int J Pharm (2012) 0.81
Bevasiranib for the treatment of wet, age-related macular degeneration. Ophthalmol Eye Dis (2010) 0.81
KLF4 Promotes Angiogenesis by Activating VEGF Signaling in Human Retinal Microvascular Endothelial Cells. PLoS One (2015) 0.81
Profile of conbercept in the treatment of neovascular age-related macular degeneration. Drug Des Devel Ther (2015) 0.81
Receptor tyrosine kinase inhibitors AG013764 and AG013711 reduce choroidal neovascularization in rat eye. Exp Eye Res (2007) 0.80
Lysosomal stress and lipid peroxidation products induce VEGF-121 and VEGF-165 expression in ARPE-19 cells. Graefes Arch Clin Exp Ophthalmol (2011) 0.80
Physiological and ecological implications of ocean deoxygenation for vision in marine organisms. Philos Trans A Math Phys Eng Sci (2017) 0.79
Modulation of choroidal neovascularization by subretinal injection of retinal pigment epithelium and polystyrene microbeads. Mol Vis (2009) 0.79
Specific inhibition of serine/arginine-rich protein kinase attenuates choroidal neovascularization. Mol Vis (2013) 0.79
[Intravitreal administration of triamcinolone and bevacizumab for pigment epithelial detachment in conjunction with AMD]. Ophthalmologe (2008) 0.78
Comparison of the efficacy of anti-VEGF monotherapy versus PDT and intravitreal anti-VEGF combination treatment in AMD: a Meta-analysis and systematic review. Int J Ophthalmol (2016) 0.78
Knockdown of the placental growth factor gene inhibits laser induced choroidal neovascularization in a murine model. J Ophthalmic Vis Res (2013) 0.78
Role of ranibizumab in management of macular degeneration. Indian J Ophthalmol (2007) 0.78
Mesenchymal stem cell-based HSP70 promoter-driven VEGFA induction by resveratrol promotes angiogenesis in a mouse model. Cell Stress Chaperones (2015) 0.78
Low Mmp 9 and VEGF levels predict good oncologic outcome in mid and low rectal cancer patients with neoadjuvant chemoradiation. BMC Clin Pathol (2012) 0.77
Ocular Safety of Intravitreal Propranolol and Its Efficacy in Attenuation of Choroidal Neovascularization. Invest Ophthalmol Vis Sci (2015) 0.76
Glycobiology of ocular angiogenesis. Glycobiology (2014) 0.76
Predictors of visual response to intravitreal bevacizumab for treatment of neovascular age-related macular degeneration. J Ophthalmol (2013) 0.76
Storage stability of bevacizumab in polycarbonate and polypropylene syringes. Eye (Lond) (2015) 0.75
Controlled Release of Collagen-Binding SDF-1α Improves Cardiac Function after Myocardial Infarction by Recruiting Endogenous Stem Cells. Sci Rep (2016) 0.75
Bone marrow-derived cells in ocular neovascularization: contribution and mechanisms. Angiogenesis (2016) 0.75
Emerging options for the management of age-related macular degeneration with stem cells. Stem Cells Cloning (2010) 0.75
Up-Regulation of ENO1 by HIF-1α in Retinal Pigment Epithelial Cells after Hypoxic Challenge Is Not Involved in the Regulation of VEGF Secretion. PLoS One (2016) 0.75
Does matrix metalloproteinase-3 polymorphism play a role in age-related macular degeneration in patients with myocardial infarction? Medicina (Kaunas) (2012) 0.75
Physical disruption of cell-cell contact induces VEGF expression in RPE cells. Mol Vis (2017) 0.75
Fundus autofluorescence and fate of glycoxidized particles injected into subretinal space in rabbit age-related macular degeneration model. Graefes Arch Clin Exp Ophthalmol (2009) 0.75
Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol (1977) 41.93
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (1992) 18.26
Vascular endothelial growth factor is a secreted angiogenic mitogen. Science (1989) 16.71
Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science (1989) 8.10
The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol (1991) 5.61
Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest (1992) 4.43
Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci (1996) 3.21
Pathophysiology of age-related macular degeneration. Surv Ophthalmol (1987) 3.17
The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J Biol Chem (1992) 2.85
The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem (1996) 2.75
Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol (1997) 2.73
Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest (1993) 2.71
Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun (1992) 2.47
Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol (1998) 2.33
VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J Biol Chem (1997) 2.12
Growth factor localization in choroidal neovascular membranes of age-related macular degeneration. Invest Ophthalmol Vis Sci (1994) 1.90
Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. Am J Ophthalmol (1996) 1.90
Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Mol Med (1995) 1.78
Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. Invest Ophthalmol Vis Sci (1998) 1.68
Growth factors in age-related macular degeneration: pathogenic and therapeutic implications. Ophthalmic Res (1997) 1.68
Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol (1997) 1.65
Localization of vascular endothelial growth factor in human retina and choroid. Arch Ophthalmol (1996) 1.65
Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res (1996) 1.64
Adenovirus vector-mediated in vivo gene transfer into adult murine retina. Invest Ophthalmol Vis Sci (1994) 1.63
Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. Exp Eye Res (1997) 1.58
Mechanisms of retinal and choroidal neovascularization. Invest Ophthalmol Vis Sci (1994) 1.52
Vascular endothelial growth factor expression in choroidal neovascularization in rats. Graefes Arch Clin Exp Ophthalmol (1997) 1.44
A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum Mol Genet (1994) 1.41
Histopathologic study of the effect of retinal detachment surgery on 49 eyes obtained post mortem. Am J Ophthalmol (1987) 1.28
Expression of cell adhesion molecules and vascular endothelial growth factor in experimental choroidal neovascularisation in the rat. Br J Ophthalmol (1998) 1.11
Phenotype correction in retinal pigment epithelium in murine mucopolysaccharidosis VII by adenovirus-mediated gene transfer. Proc Natl Acad Sci U S A (1995) 1.07
Expression of vascular endothelial growth factor and its receptor (KDR/flk-1) mRNA in experimental choroidal neovascularization. Curr Eye Res (1999) 1.06
Basic fibroblast growth factor experimentally induced choroidal angiogenesis in the minipig. Curr Eye Res (1994) 1.06
Human Müller cells express VEGF183, a novel spliced variant of vascular endothelial growth factor. Invest Ophthalmol Vis Sci (1999) 1.05
Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes. Br J Ophthalmol (1997) 1.04
A new procedure for fundus photography and fluorescein angiography in small laboratory animal eyes. Curr Eye Res (1994) 0.96
A simple flow cytometric technique to quantify rod outer segment phagocytosis in cultured retinal pigment epithelial cells. Curr Eye Res (1996) 0.93
Angiogenesis inhibition in age-related macular degeneration. Ophthalmology (1995) 0.89
Cell release of bioactive fibroblast growth factor 2 by exon 6-encoded sequence of vascular endothelial growth factor. J Biol Chem (1997) 0.89
Editorial: Bruch's membrane and vascular growth. Invest Ophthalmol (1976) 0.88
Gene therapy for inherited retinal degeneration. Br J Ophthalmol (1997) 0.86
Recombinant adenovirus-mediated gene transfer into the adult rat retina. Curr Eye Res (1998) 0.84
Recombinant adenovirus-mediated gene delivery into the rat retinal pigment epithelium in vivo. Aust N Z J Ophthalmol (1998) 0.78
Age-related macular degeneration: current aspects of pathogenesis and treatment. Yan Ke Xue Bao (1991) 0.78
Subretinal neovascularization as a complication of drainage of subretinal fluid. Retina (1983) 0.78
Severe corneoscleral infection. A complication of beta irradiation scleral necrosis following pterygium excision. Arch Ophthalmol (1993) 2.32
Gamma nails and dynamic hip screws for peritrochanteric fractures. A randomised prospective study in elderly patients. J Bone Joint Surg Br (1992) 2.27
The influence of cerebrospinal fluid pressure on the lamina cribrosa tissue pressure gradient. Invest Ophthalmol Vis Sci (1995) 2.19
Pterygium excision with conjunctival autografting: an effective and safe technique. Br J Ophthalmol (1993) 2.15
Late complications of pterygium treatment. Br J Ophthalmol (1980) 2.11
Lipofuscin of the retinal pigment epithelium: a review. Eye (Lond) (1995) 2.10
Clinical results of implantation of the Chirila keratoprosthesis in rabbits. Br J Ophthalmol (1998) 2.02
Laser-induced chorioretinal venous anastomosis for treatment of nonischemic central retinal vein occlusion. Arch Ophthalmol (1995) 1.80
Limb fracture pattern in different pediatric age groups: a study of 3,350 children. J Orthop Trauma (1993) 1.68
Identification of skeletal muscle precursor cells in vivo by use of MyoD1 and myogenin probes. Cell Tissue Res (1992) 1.67
The correlation between cerebrospinal fluid pressure and retrolaminar tissue pressure. Invest Ophthalmol Vis Sci (1998) 1.62
Retinal detachment and its relation to cataract surgery. Br J Ophthalmol (1989) 1.56
Ridley intraocular lens revisited: chemical analysis of residuals in the original lens material. J Cataract Refract Surg (1989) 1.54
Prevalence of diabetic complications in relation to risk factors. Diabetes (1986) 1.51
The distribution of angioarchitectural changes within the vicinity of the arteriovenous crossing in branch retinal vein occlusion. Ophthalmology (1998) 1.49
Corneal replacement using a synthetic hydrogel cornea, AlphaCor: device, preliminary outcomes and complications. Eye (Lond) (2003) 1.41
Keratoprostheses: advancing toward a true artificial cornea. Surv Ophthalmol (1997) 1.39
A new magnifying indirect stereo ophthalmoscope. Retina (1992) 1.39
First Australian excimer laser keratectomy patients. Aust N Z J Ophthalmol (1992) 1.38
Laser-induced chorioretinal venous anastomosis for nonischemic central retinal vein occlusion: evaluation of the complications and their risk factors. Am J Ophthalmol (1998) 1.38
The Arden grating acuity: effect of age and optical factors in the normal patient, with prediction of the false negative rate in screening for glaucoma. Br J Ophthalmol (1981) 1.35
Fungal corneoscleritis complicating beta-irradiation-induced scleral necrosis following pterygium excision. Eye (Lond) (1993) 1.27
An effective treatment of comminuted fractures of the distal radius. J Hand Surg Am (1990) 1.22
Poly(2-hydroxyethyl methacrylate) sponges as implant materials: in vivo and in vitro evaluation of cellular invasion. Biomaterials (1993) 1.19
Infective keratitis in soft contact lens wearers. Br J Ophthalmol (1977) 1.16
Automated extraction and quantification of macular drusen from fundal photographs. Aust N Z J Ophthalmol (1994) 1.16
Vitreous structure. 3. Composition of bovine vitreous collagen. Invest Ophthalmol (1972) 1.12
Retinal artery and vein pressures in the dog and their relationship to aortic, intraocular, and cerebrospinal fluid pressures. Microvasc Res (1997) 1.12
Closed reduction and percutaneous pinning for type III displaced supracondylar fractures of the humerus in children. J Orthop Trauma (1995) 1.11
Expression of cell adhesion molecules and vascular endothelial growth factor in experimental choroidal neovascularisation in the rat. Br J Ophthalmol (1998) 1.11
Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization. Hum Gene Ther (2001) 1.11
Chorioretinal biopsy in dogs. Invest Ophthalmol Vis Sci (1980) 1.09
Non-mydriatic fundus photography: a viable alternative to fundoscopy for identification of diabetic retinopathy in an Aboriginal population in rural Western Australia? Aust N Z J Ophthalmol (1998) 1.09
Atypical Femur Fractures Associated With Diphosphonate Use. J Am Acad Orthop Surg (2016) 1.07
A case for electronic manipulation of medical images? J Audiov Media Med (1999) 1.07
Proton irradiation of small choroidal malignant melanomas. Am J Ophthalmol (1977) 1.04
Evaluation of adeno-associated virus-mediated gene transfer into the rat retina by clinical fluorescence photography. Hum Gene Ther (1999) 1.02
Clinical results of hydrogel lens implantation. J Cataract Refract Surg (1986) 1.01
Macular oedema and retinal branch vein occlusion. Aust J Ophthalmol (1980) 1.00
Calcification of poly(2-hydroxyethyl methacrylate) hydrogel sponges implanted in the rabbit cornea: a 3-month study. J Biomater Sci Polym Ed (2000) 1.00
The retinal oxygen profile in cats. Invest Ophthalmol Vis Sci (1983) 1.00
Measurement of cervical canal sagittal diameter in Chinese males with cervical spondylotic myelopathy. Zhonghua Yi Xue Za Zhi (Taipei) (1994) 0.99
Osteonecrosis of the femoral head treated with cementless total hip arthroplasty. A comparison with other diagnoses. J Arthroplasty (1997) 0.99
Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy. Gene Ther (2002) 0.99
International transmission of tele-ophthalmology images. J Telemed Telecare (2000) 0.98
Matrix metalloproteinase (MMP) expression in experimental choroidal neovascularization. Curr Eye Res (2000) 0.98
The patency of the retinal vasculature to erythrocytes in retinal vascular disease. Invest Ophthalmol Vis Sci (1990) 0.98
Pathology of vitreous membranes and the effect of haemorrhage and new vessels on the vitreous. Trans Ophthalmol Soc U K (1975) 0.97
Fracture of the femoral neck in younger adults. A new method of treatment for delayed and nonunions. Clin Orthop Relat Res (1993) 0.97
Progression of myelinated retinal nerve fibers. Am J Ophthalmol (1999) 0.96
Bilateral streptococcal corneoscleritis complicating beta irradiation induced scleral necrosis. Br J Ophthalmol (1993) 0.96
Robotic ocular ultramicrosurgery. Aust N Z J Ophthalmol (1998) 0.95
Modulation of cathepsin D activity in retinal pigment epithelial cells. Biochem J (1997) 0.95
Dendrimer delivery of an anti-VEGF oligonucleotide into the eye: a long-term study into inhibition of laser-induced CNV, distribution, uptake and toxicity. Gene Ther (2005) 0.94
Long-term global retinal microvascular changes in a transgenic vascular endothelial growth factor mouse model. Diabetologia (2006) 0.94
Evaluation of a portable fundus camera for use in the teleophthalmologic diagnosis of glaucoma. J Glaucoma (1999) 0.93
Methods and limits of digital image compression of retinal images for telemedicine. Invest Ophthalmol Vis Sci (2000) 0.93
Tele-ophthalmology screening for retinal and anterior segment diseases. J Telemed Telecare (2000) 0.93
Vitreous structure. I. Distribution of hyaluronate and protein. Invest Ophthalmol (1972) 0.93
Telemedical diagnosis of anterior segment eye diseases: validation of digital slit-lamp still images. Eye (Lond) (2008) 0.93
The transcription of MyoD1 and myogenin genes in thymic cells in vivo. Exp Cell Res (1992) 0.93
A simple flow cytometric technique to quantify rod outer segment phagocytosis in cultured retinal pigment epithelial cells. Curr Eye Res (1996) 0.93
Pseudomonas endophthalmitis associated with scleral necrosis. Br J Ophthalmol (1980) 0.93
Aqueous humor catecholamines. Curr Eye Res (1984) 0.92
Correlation between autofluorescent debris accumulation and the presence of partially processed forms of cathepsin D in cultured retinal pigment epithelial cells challenged with rod outer segments. Exp Eye Res (1996) 0.92
Trachoma: 1985 update in Western Australia. Aust N Z J Ophthalmol (1986) 0.91
Distribution of cathepsin D in human eyes with or without age-related maculopathy. Exp Eye Res (1999) 0.91
Preclinical safety evaluation of subretinal AAV2.sFlt-1 in non-human primates. Gene Ther (2011) 0.91
Assessment of anticollagenase treatments after insertion of a keratoprosthetic material in the rabbit cornea. Cornea (1998) 0.91
A quantitative study of the lateral spread of Müller cell responses to retinal lesions in the rabbit. J Comp Neurol (1993) 0.90
Regeneration and myogenic cell proliferation correlate with taurine levels in dystrophin- and MyoD-deficient muscles. Anat Rec (1998) 0.89
Relation between pressure determined by ophthalmodynamometry and aortic pressure in the dog. Br J Ophthalmol (1998) 0.89
Quantitation of muscle precursor cell activity in skeletal muscle by Northern analysis of MyoD and myogenin expression: Application to dystrophic (mdx) mouse muscle. Mol Cell Neurosci (1992) 0.88
Kinetic studies on phagocytosis and lysosomal digestion of rod outer segments by human retinal pigment epithelial cells in vitro. Exp Cell Res (1994) 0.88
Improved method for calculation of corneal topography for any photokeratoscope geometry. Optom Vis Sci (1991) 0.88
Proton irradiation of choroidal melanomas. Preliminary results. Arch Ophthalmol (1978) 0.88
Detection and possible functions of a cysteine protease involved in digestion of rod outer segments by retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (1994) 0.87
Long-term observations of proton-irradiated monkey eyes. Arch Ophthalmol (1979) 0.87
Tissue interaction with hydrogel sponges implanted in the rabbit cornea. Cornea (1993) 0.87
Poly(1-vinyl-2-pyrrolidinone) hydrogels as vitreous substitutes: histopathological evaluation in the animal eye. J Biomater Sci Polym Ed (1996) 0.87
Iron-binding proteins in vitreous humour. Biochim Biophys Acta (1983) 0.87
Effect of cyclic AMP on cellular contractility and DNA synthesis in chorioretinal fibroblasts maintained in collagen matrices. Exp Cell Res (1984) 0.87
A new look at the sequential development of elbow-ossification centers in children. J Pediatr Orthop (1998) 0.86
Ligamentotaxis and bone grafting for comminuted fractures of the distal radius. J Bone Joint Surg Br (1989) 0.86
Interlocking intramedullary nailing for supracondylar and intercondylar fractures of the distal part of the femur. J Bone Joint Surg Am (1991) 0.85
Hereditary cataracts in canaries. J Am Vet Med Assoc (1983) 0.85
Generation of transgenic mice with mild and severe retinal neovascularisation. Br J Ophthalmol (2005) 0.85
Fluorescein angiographic findings in three patients with long-term intravitreal liquid silicone. Br J Ophthalmol (1989) 0.85
Initial clinical experience with tissue plasminogen activator (tPA) assisted removal of submacular haemorrhage. Eye (Lond) (1995) 0.84
Assessing the risk of diabetic retinopathy. Am J Ophthalmol (1984) 0.84
Corneal endothelial loss with new intraocular lenses. Am J Ophthalmol (1984) 0.84